Abstract
Cancer cells can evade natural killer (NK) cell activity, thereby limiting anti-tumor immunity. To reveal genetic determinants of susceptibility to NK cell activity, we examined interacting NK cells and blood cancer cells using single-cell and genome-scale functional genomics screens. Interaction of NK and cancer cells induced distinct activation and type I interferon (IFN) states in both cell types depending on the cancer cell lineage and molecular phenotype, ranging from more sensitive myeloid to less sensitive B-lymphoid cancers. CRISPR screens in cancer cells uncovered genes regulating sensitivity and resistance to NK cell-mediated killing, including adhesion-related glycoproteins, protein fucosylation genes, and transcriptional regulators, in addition to confirming the importance of antigen presentation and death receptor signaling pathways. CRISPR screens with a single-cell transcriptomic readout provided insight into underlying mechanisms, including regulation of IFN-γ signaling in cancer cells and NK cell activation states. Our findings highlight the diversity of mechanisms influencing NK cell susceptibility across different cancers and provide a resource for NK cell-based therapies.
Original language | English |
---|---|
Pages (from-to) | 2816-2835.e13 |
Journal | Immunity |
Volume | 56 |
Issue number | 12 |
DOIs | |
State | Published - 12 Dec 2023 |
Externally published | Yes |
Keywords
- cancer
- CRISPR screening
- CROP-seq
- functional genomics
- immunotherapy resistance
- leukemia
- lymphoma
- myeloma
- NK cell
- single-cell RNA sequencing